ATYR

Atyr Pharma Inc Cross-source read$0.43 0.46%
Health CareCUSIP 002120202· EOD Sep 11, 2026

Among active 13F managers last quarter, 12 opened and 12 added, while 9 reduced; the largest holder to move was Millennium Management LLC (new position). Over the last 180 days, 1 insider bought and none sold, a net +$50K in open-market trades.

Tracked 13F holders
98
40 in Q2 2026 filings
13F value (tracked)
$26.4M
Smart-money readBullish
Net sellingNet buying
Funds · active managers, latest 13F
24 adding · 9 trimming
Insiders · Form 4 open-market, 180d
1 buying · 0 selling · +$50K
US House · STOCK Act, 180d
0 buying · 0 selling

Funds lean in and no leg opposes.

Price & smart-money activity

$0.43 0.46%5Y -95.2%
$0.40$3.06$5.72$8.38$11.042021202220232024202520261134823114572587913779448125413831472113226182828323021132322111212
Hover for who · click for detailEnd-of-day closing prices52w $0.40 – $6.03

Who owns ATYR?

98 tracked 13F filers · ranked by shares held

98 tracked 13F filers disclose a position in ATYR as of the latest SEC 13F filings, a combined $26.4M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1Federated Hermes, Inc.10.5M
$8.2M
Held
Q1 2026
2UBS Group AG3.9M
$3.0M
+138%
Added · +2.2M sh
Q1 2026
3Vanguard Capital Management LLC3.8M
$2.3M
−0.1%
Reduced · −4K sh
Q2 2026
4FMR LLC2.5M
$1.5M
−83%
Reduced · −12.2M sh
Q2 2026
5BlackRock, Inc.1.8M
$1.1M
−72%
Reduced · −4.6M sh
Q2 2026
6Kalehua Capital Management LLC1.8M
$1.1M
New
+1.8M sh
Q2 2026
7Millennium Management LLC1.6M
$1.3M
New
+1.6M sh
Q1 2026
8Citadel Advisors LLC1.2M
$741K
26×
Added · +1.2M sh
Q2 2026
9Morgan Stanley1.2M
$956K
−13%
Reduced · −178K sh
Q1 2026
10Geode Capital Management, LLC1.2M
$703K
−51%
Reduced · −1.2M sh
Q2 2026
11Two Sigma Investments, LP1.1M
$893K
+152%
Added · +690K sh
Q1 2026
12Susquehanna International Group, LLP867K
$676K
+13%
Added · +102K sh
Q1 2026
13Northern Trust Corp711K
$555K
+1.3%
Added · +9K sh
Q1 2026
14Vanguard Fiduciary Trust Co576K
$344K
−12%
Reduced · −76K sh
Q2 2026
15AQR Capital Management LLC496K
$387K
−36%
Reduced · −274K sh
Q1 2026
16State Street Corp495K
$295K
−72%
Reduced · −1.3M sh
Q2 2026
17Bank Of America Corp304K
$237K
+140%
Added · +177K sh
Q1 2026
18Goldman Sachs Group Inc283K
$221K
−18%
Reduced · −62K sh
Q1 2026
19Nuveen, LLC229K
$179K
+0.6%
Added · +1K sh
Q1 2026
20Charles Schwab Investment Management Inc211K
$164K
−5.0%
Reduced · −11K sh
Q1 2026
21Bank of New York Mellon Corp194K
$151K
~0%
Reduced · −1 sh
Q1 2026
22Group One Trading LLC139K
$83K
−25%
Reduced · −45K sh
Q2 2026
23Marshall Wace, LLP138K
$108K
New
+138K sh
Q1 2026
24XTX Topco Ltd111K
$87K
+40%
Added · +32K sh
Q1 2026
25Deutsche Bank AG103K
$81K
−14%
Reduced · −17K sh
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is ATYR being bought or sold by institutions?

Last quarter, 12 funds opened a new position in ATYR and 12 added to an existing one, while 9 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened
12
funds took a first position
Added
12
added to an existing position
Reduced
9
reduced, still holding
Biggest moves · ranked by size of the change, positions above a floor

Funds that own ATYR also own

CompanyCo-held byTheir position there
Nvidia CorpNVDA41 funds$122.7B
Eli Lilly & CoLLY41 funds$25.7B
JPMorgan Chase & CoJPM41 funds$20.5B
Bank Of America CorpBAC41 funds$9.9B
Merck & Co. Inc.MRK41 funds$9.7B
Unitedhealth Group IncUNH41 funds$9.4B
Intuitive Surgical IncISRG41 funds$8.2B
Apple IncAAPL40 funds$94.1B
Microsoft CorpMSFT40 funds$83.3B
Amazon.com IncAMZN40 funds$65.8B
Broadcom IncAVGO40 funds$48.3B
Alphabet Inc-CL AGOOGL40 funds$46.0B

Ranked by how many of ATYR's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in ATYR.

Insider activity (Form 4)

Full insider page →
Buys · 180d
$50K
1 insider
Net · 180d
$50K
1 open-market transaction
DateInsiderRoleActionSharesValue
May 27, 2026Schimmel PaulDirectorBuy (P)100K$50K
Feb 4, 2026Broadfoot Jill MarieChief Financial OfficerSell (S)2K$2K
Feb 4, 2026Shukla SanjayPresident and CEO, DirectorSell (S)4K$4K
Feb 4, 2026Denyes NancyGeneral CounselSell (S)1K$1K
Oct 9, 2025Schimmel PaulDirectorBuy (P)318K$299K
Oct 8, 2025Schimmel PaulDirectorBuy (P)682K$614K
Mar 17, 2025Gross Jane ADirectorBuy (P)4K$15K
Feb 4, 2025Broadfoot Jill MarieChief Financial OfficerSell (S)1K$5K
Feb 4, 2025Denyes NancyGeneral CounselSell (S)899$3K
Jul 24, 2024Schimmel PaulDirectorBuy (P)52K$101K
Jul 23, 2024Schimmel PaulDirectorBuy (P)7K$12K
Jul 22, 2024Schimmel PaulDirectorBuy (P)41K$71K

Do institutions, insiders and Congress agree?

Confluence: insiders and funds buying

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
3033
Insiders
Form 4 open-market
10+$50K
US House
STOCK Act trades
00$0
Sector rotation
ATYR is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Institutional ownership over time

40 tracked filers in Q2 2026 filingsstill filing
051102Q3 2024Q1 2025Q3 2025Q1 2026Q2 2026
tracked filers holding their reported valueQ2 2026 filings so far: $8.3M
Each bar counts tracked filers with a position in that quarter's filings, so the newest bar excludes filers still on an earlier quarter. Arkolith's tracked universe has grown over this window; part of any long-run rise is coverage, not new buyers.

Recent filings

15 most recent

Keep exploring

Connected entities for ATYR

Browse more

Build

Ask your agent what changed in ATYR

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/ATYR/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for ATYR.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for ATYR. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.